Laddar...
Acute respiratory distress syndrome; A rare complication caused by usage of ruxolitinib
Ruxolitinib-associated acute respiratory distress has rarely been reported, mostly due to discontinuation of treatment. Herein we report a 58-year-old male patient with primary myelofibrosis who presented with malaise and dyspnea 15 days after initiation of the treatment. The patient was diagnosed a...
Sparad:
| I publikationen: | Respir Med Case Rep |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Elsevier
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5608559/ https://ncbi.nlm.nih.gov/pubmed/28970999 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2017.09.003 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|